This page lists the SEC filings reported by TYNDALL CAPITAL PARTNERS L P.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | TYNDALL CAPITAL PARTNERS L P | Cyclerion Therapeutics, Inc. | 164,429 | 6.7% | EDGAR |
| SC 13G | 2023-09-05 | TYNDALL CAPITAL PARTNERS L P | Cyclerion Therapeutics, Inc. | 121,638 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-14 | TYNDALL CAPITAL PARTNERS L P | Onconova Therapeutics, Inc. | 26,042 | 0.1% | EDGAR |
| SC 13G/A | 2019-11-18 | TYNDALL CAPITAL PARTNERS L P | Onconova Therapeutics, Inc. | 499,041 | 6.1% | EDGAR |
| SC 13G/A | 2019-02-25 | TYNDALL CAPITAL PARTNERS L P | Onconova Therapeutics, Inc. | 842,314 | 14.8% | EDGAR |
| SC 13G/A | 2018-02-14 | TYNDALL CAPITAL PARTNERS L P | Onconova Therapeutics, Inc. | 1,387,646 | 12.4% | EDGAR |
| SC 13G | 2016-08-18 | TYNDALL CAPITAL PARTNERS L P | Onconova Therapeutics, Inc. | 911,456 | 13.5% | EDGAR |
| SC 13G/A | 2015-02-17 | TYNDALL CAPITAL PARTNERS L P | Ottawa Savings Bancorp, Inc. | 130,237 | 6.1% | EDGAR |
| SC 13G/A | 2013-02-14 | TYNDALL CAPITAL PARTNERS L P | Ottawa Savings Bancorp, Inc. | 129,237 | 6.1% | EDGAR |
| SC 13G/A | 2012-02-14 | TYNDALL CAPITAL PARTNERS L P | WAYNE SAVINGS BANCSHARES INC /DE/ | 64,720 | 2.2% | EDGAR |
| SC 13G/A | 2012-02-14 | TYNDALL CAPITAL PARTNERS L P | Myrexis, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2012-02-14 | TYNDALL CAPITAL PARTNERS L P | First Financial Northwest, Inc. | 373,168 | 2.0% | EDGAR |
| SC 13G/A | 2012-02-14 | TYNDALL CAPITAL PARTNERS L P | Ottawa Savings Bancorp, Inc. | 129,311 | 6.1% | EDGAR |
| SC 13G/A | 2012-02-14 | TYNDALL CAPITAL PARTNERS L P | Eagle Bancorp Montana, Inc. | 119,790 | 3.1% | EDGAR |
| SC 13D/A | 2011-07-29 | TYNDALL CAPITAL PARTNERS L P | Furiex Pharmaceuticals, Inc. | 13,872 | 0.1% | EDGAR |
| SC 13G/A | 2011-02-14 | TYNDALL CAPITAL PARTNERS L P | First Financial Northwest, Inc. | 984,952 | 5.2% | EDGAR |
| SC 13G/A | 2011-02-14 | TYNDALL CAPITAL PARTNERS L P | Ocean Shore Holding Co. | 324,000 | 4.4% | EDGAR |
| SC 13G/A | 2011-02-14 | TYNDALL CAPITAL PARTNERS L P | WILLIAM PENN BANCORP INC | 225,711 | 6.2% | EDGAR |
| SC 13G/A | 2011-02-14 | TYNDALL CAPITAL PARTNERS L P | WALTER INVESTMENT MANAGEMENT CORP | 304,700 | 1.2% | EDGAR |
| SC 13D | 2010-06-28 | TYNDALL CAPITAL PARTNERS L P | Furiex Pharmaceuticals, Inc. | 700,000 | 7.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.